By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Allegro Ophthalmics LLC 

31473 Rancho Viejo Road, Suite 204

San Juan Capistrano  California  92675  U.S.A.
Phone: 949-940-8130 Fax: 949-940-8121


SEARCH JOBS


Industry
Biotechnology






Company News
William J. Link, PhD, Joins Allegro Ophthalmics LLC’ Board Of Directors 11/21/2016 10:33:32 AM
Allegro Ophthalmics LLC Announces Positive Topline Results From DEL MAR Phase 2b Trial Evaluating Luminate In Patients With Diabetic Macular Edema 10/13/2016 12:54:01 PM
Allegro Ophthalmics LLC Announces Last Patient Enrolled In PACIFIC Phase IIb Clinical Trial Of Luminate For Non-Proliferative Diabetic Retinopathy 10/3/2016 8:47:50 AM
Ron Kurtz, MD, And Mark Livingston Join Allegro Ophthalmics LLC’ Board Of Directors 8/1/2016 11:10:29 AM
Allegro Ophthalmics LLC Announces Two Executive Promotions 3/15/2016 10:50:14 AM
Allegro Ophthalmics LLC Announces Last Patient Enrolled In DEL MAR Phase IIb Clinical Trial Of Luminate For The Treatment Of Diabetic Macular Edema 1/5/2016 10:38:09 AM
Allegro Ophthalmics LLC Names Scott Cooper As Chief Financial Officer And Vice President Of Business Development And Mohamed Genead, MD, As Executive Medical Director 10/21/2015 8:07:29 AM
Allegro Ophthalmics LLC Announces Positive Topline Results From Phase II Trial Evaluating Luminate® In Patients With Vitreomacular Traction Or Vitreomacular Adhesion 7/13/2015 8:12:50 AM
Allegro Ophthalmics LLC Announces Issuance Of U.S. Patent For First-In-Class Integrin Peptide Therapy Candidate Luminate 5/18/2015 10:38:56 AM
Allegro Ophthalmics LLC Begins Phase II Clinical Study Of Luminate® For Non-Proliferative Diabetic Retinopathy 5/4/2015 7:59:13 AM
12
//-->